Complera side effects - from FDA reports


Summary

In this review, we analyze Complera side effects by the time on the drug, gender and age of the people who have side effects while taking Complera. The review is based on 384 people who have side effects while taking the drug from FDA, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


Complera

Complera has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate. It is often used in hiv infection. (latest outcomes from Complera 390 users)

On Dec, 31, 2017

384 people who take Complera are studied.


Number of reports submitted per year:

Complera side effects.

Most common side effects over time *:

< 1 month:
  • rash
  • nephrolithiasis
  • rash generalised
  • rash maculo-papular
  • rash pruritic
  • vision blurred
  • yellow skin
1 - 6 months:
  • tremor
  • vomiting
  • acute promyelocytic leukaemia
  • fatigue
  • foetal death
  • liver function test abnormal
  • paraesthesia
  • thrombocytopenia
  • tinnitus
  • depression
6 - 12 months:
  • gynaecomastia
  • insomnia
  • rash
  • sepsis
1 - 2 years:
  • pregnancy
  • abortion spontaneous
  • osteoporosis
2 - 5 years:
  • fracture
  • renal failure
not specified:
  • nausea
  • rash
  • viral load increased
  • weight decreased
  • weight increased
  • pain in extremity
  • suicidal ideation
  • headache
  • pregnancy
  • vomiting

Most common side effects by gender *:

female:
  • pregnancy
  • pain in extremity
  • rash
  • depression
  • insomnia
  • maternal exposure during pregnancy
  • vision blurred
  • breast discharge
  • foetal death
  • foetal exposure during pregnancy
male:
  • nausea
  • rash
  • vomiting
  • weight increased
  • viral load increased
  • suicidal ideation
  • headache
  • pain
  • paraesthesia
  • tremor

Most common side effects by age *:

0-1:
  • foetal exposure during pregnancy
  • weight decrease neonatal
  • weight decreased
20-29:
  • pregnancy
  • nausea
  • vision blurred
  • amenorrhoea
  • death
  • fracture
  • gynaecomastia
  • hiv test positive
  • muscular weakness
  • myocardial infarction
30-39:
  • suicidal ideation
  • nausea
  • foetal death
  • headache
  • liver function test abnormal
  • rash
  • weight increased
  • abortion spontaneous
  • alanine aminotransferase increased
  • alopecia
40-49:
  • vomiting
  • depression
  • paraesthesia
  • pneumonia
  • rash
  • tremor
  • urticaria
  • weight increased
  • abdominal pain upper
  • acute promyelocytic leukaemia
50-59:
  • rash
  • renal tubular disorder
  • viral load increased
  • bone disorder
  • dizziness
  • pain in extremity
  • throat irritation
  • angina pectoris
  • anxiety
  • back pain
60+:
  • pain in extremity
  • blood creatine increased
  • blood glucose increased
  • drug ineffective
  • headache
  • hypertension
  • joint swelling
  • myalgia
  • nightmare
  • osteopenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Are you taking Complera?

Expand the study to include reports from both FDA and eHealthMe

Complera side effects from FDA and eHealthMe reports

Related studies

All Complera side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Complera (emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate) is often used to treat hiv infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

User posts to the study

More posts >